Alzamend Neuro Inc - ROE
ALZN
Price:
$1.43
Market Cap:
$5.44M
Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is...[Read more]
Industry
Biotechnology
IPO Date
2021-06-15
Stock Exchange
NASDAQ
Ticker
ALZN
PE Ratio
[-0.37]
ROE
[-277.71%]
Current Ratio
[1.31]
Dividend Yield
[0%]
Enterprise Value
[4.73M]
Dividend History
The ROE as of August 2026 (TTM) for Alzamend Neuro Inc (ALZN) is -277.71%
According to Alzamend Neuro Inc’s latest financial reports and current stock price. The company's current ROE is -277.71%. This represents a change of 96.42% compared to the average of -141.39% of the last 4 quarters.
Alzamend Neuro Inc (ALZN) Historical ROE (quarterly & annually)
How has ALZN ROE performed in the past?
The mean historical ROE of Alzamend Neuro Inc over the last ten years is -360.14%. The current -277.71% ROE has changed -22.89% with respect to the historical average. Over the past ten years (40 quarters), ALZN's ROE was at its highest in in the July 2023 quarter at 3.13%. The ROE was at its lowest in in the July 2016 quarter at -400.17%.
Average
-360.14%
Median
-182.24%
Minimum
-1534.32%
Maximum
383.46%
Alzamend Neuro Inc (ALZN) ROE by Quarter and Year
Discovering the peaks and valleys of Alzamend Neuro Inc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.72%
Maximum Annual ROE = 383.46%
Minimum Annual Increase = -178.49%
Minimum Annual ROE = -1534.32%
| Year | ROE | Change |
|---|---|---|
| 2026 | -1196.43% | 951.58% |
| 2025 | -113.78% | -129.67% |
| 2024 | 383.46% | -178.49% |
| 2023 | -488.53% | 427.63% |
| 2022 | -92.59% | -63.07% |
| 2021 | -250.71% | -53.29% |
| 2020 | -536.72% | -65.02% |
| 2019 | -1534.32% | 3.72% |
| 2018 | -40.18% | -114.97% |
| 2017 | 268.41% | -99.59% |
Alzamend Neuro Inc (ALZN) Average ROE
How has ALZN ROE performed in the past?
The current ROE of Alzamend Neuro Inc (ALZN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-308.92%
5-year avg
-301.57%
10-year avg
-360.14%
Alzamend Neuro Inc (ALZN) ROE vs. Peers
How is ALZN’s ROE compared to its peers?
Alzamend Neuro Inc’s ROE is greater than BioCardia, Inc. (-5456.14%), greater than Creative Medical Technology Holdings, Inc. (-88.50%), greater than HCW Biologics Inc. (-102.39%), greater than Acurx Pharmaceuticals, Inc. (-153.93%), greater than Aprea Therapeutics, Inc. (-59.54%), greater than Adial Pharmaceuticals, Inc. (-162.83%), greater than Kiora Pharmaceuticals, Inc. (-59.30%), less than NeuroSense Therapeutics Ltd. (1.07%), greater than Cardio Diagnostics Holdings, Inc. (-78.82%), greater than Phio Pharmaceuticals Corp. (-77.34%),
| Company | ROE | Market cap |
|---|---|---|
| -5456.14% | $5.51M | |
| -88.50% | $1.73M | |
| -102.39% | $1.19M | |
| -153.93% | $2.33M | |
| -59.54% | $4.03M | |
| -162.83% | $3.89M | |
| -59.30% | $11.26M | |
| 1.07% | $19.59M | |
| -78.82% | $3.62M | |
| -77.34% | $12.43M |
Build a custom stock screener for Alzamend Neuro Inc (ALZN) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alzamend Neuro Inc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Alzamend Neuro Inc (ALZN) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Alzamend Neuro Inc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Alzamend Neuro Inc's ROE?
How is the ROE calculated for Alzamend Neuro Inc (ALZN)?
What is the highest ROE for Alzamend Neuro Inc (ALZN)?
What is the 3-year average ROE for Alzamend Neuro Inc (ALZN)?
What is the 5-year average ROE for Alzamend Neuro Inc (ALZN)?
How does the current ROE for Alzamend Neuro Inc (ALZN) compare to its historical average?